Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Glycobac, LLC in April, 2018 for $217,385.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM125397-01A1 | Phase I | 217,385 | April 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Glycobac, LLC in March, 2020 for $224,597.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM136071-01 | Phase I | 224,597 | March 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Glycobac, LLC in September, 2016 for $939,580.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM102982-03 | Phase II | 939,580 | September 1, 2016 | |||||||
A SBIR Phase I contract was awarded to Glycobac, LLC for $599,241.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM102982-01A1 | Phase I | 599,241 | ||||||||
A SBIR Phase I contract was awarded to Glycobac, LLC for $148,202.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM109504-01 | Phase I | 148,202 | ||||||||
A SBIR Phase I contract was awarded to Glycobac, LLC for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI112118-01 | Phase I | 225,000 |